Literature DB >> 6246887

The metabolism of cyclic nucleotides in the guinea-pig pancreas. Cyclic AMP phosphodiesterase and cyclic GMP phosphodiesterase.

P Methven, M Lemon, K Bhoola.   

Abstract

Both cyclic AMP phosphodiesterase and cyclic GMP phosphodiesterase were recovered mainly from the supernatant fractions of guinea-pig pancreas, but a higher proportion of the activity of the former was associated with the pellet fractions. The activities in the supernatant were not separated by gel filtration, but were clearly separated by subsequent chromatography on an anion-exchange resin. The activities of cyclic AMP phosphodiesterase and cyclic GMP phosphodiesterase had high-affinity (K(m) 6.5+/-1.1mum and 31.9+/-3.9mum respectively) and low-affinity (K(m) 0.56+/-0.05mm and 0.32+/-0.03mm respectively) components. The activity of neither enzyme was affected by the pancreatic secretogens, cholecystokinin-pancreozymin, secretin and carbachol. Removal of ions by gel filtration resulted in a marked reduction in cyclic nucleotide phosphodiesterase activity, which could be restored by addition of Mg(2+). Mn(2+) (3mm) was as effective as Mg(2+) (3mm) in the case of cyclic AMP phosphodiesterase, but was less than half as effective in the case of cyclic GMP phosphodiesterase. The metal-ion chelators, EDTA and EGTA, also decreased activity. Ca(2+) (1mm) did not affect the activity of cyclic nucleotide phosphodiesterase when the concentration of Mg(2+) was 3mm. At concentrations of Mg(2+) between 0.1 and 1mm, 1mm-Ca(2+) was activatory, and at concentrations of Mg(2+) below 0.1mm, 1mm-Ca(2+) was inhibitory. These results are discussed in terms of the possible significance of cyclic nucleotide phosphodiesterase in the physiological control of cyclic nucleotide concentrations during stimulus-secretion coupling.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6246887      PMCID: PMC1161601          DOI: 10.1042/bj1860491

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

1.  Different effects of lipolytic hormones and phosphodiesterase inhibitors on cyclic 3',5'-AMP levels in isolated fat cells.

Authors:  U Schwabe; R Ebert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

2.  Separation of cyclic 3',5'-nucleoside monophosphates from other nucleotides on aluminum oxide columns. Application to the assay of adenyl cyclase and guanyl cyclase.

Authors:  A A White; T V Zenser
Journal:  Anal Biochem       Date:  1971-06       Impact factor: 3.365

3.  Hydrolysis of cyclic guanosine and adenosine 3',5'-monophosphates by rat and bovine tissues.

Authors:  J A Beavo; J G Hardman; E W Sutherland
Journal:  J Biol Chem       Date:  1970-11-10       Impact factor: 5.157

Review 4.  Cyclic AMP and drug action.

Authors:  B M Breckenridge
Journal:  Annu Rev Pharmacol       Date:  1970       Impact factor: 13.820

5.  Enzyme secretion in mouse pancreas mediated by adenosine-3'5'-cyclic phosphate and inhibited by adenosine-3'-phosphate.

Authors:  R G Kulka; E Sternlicht
Journal:  Proc Natl Acad Sci U S A       Date:  1968-11       Impact factor: 11.205

6.  In vitro and in vivo effects of pancreozymin, urecholine, and cyclic AMP on rat pancreas.

Authors:  J A Morisset; P D Webster
Journal:  Am J Physiol       Date:  1971-01

7.  The intracellular localization of kallikrein, trypsin and amylase in dog pancreas.

Authors:  K D Bhoola; G Dorey
Journal:  J Physiol       Date:  1971-05       Impact factor: 5.182

8.  Adenylate cyclase in the rat pancreas properties and stimulation by hormones.

Authors:  W J Rutten; J J de Pont; S L Bonting
Journal:  Biochim Biophys Acta       Date:  1972-07-03

9.  Control of pancreatic amylase release in vitro: effects of ions, cyclic AMP, and colchicine.

Authors:  L Benz; B Eckstein; E K Matthews; J A Williams
Journal:  Br J Pharmacol       Date:  1972-09       Impact factor: 8.739

10.  The actions of dibutyryl cyclic adenosine 3',5'-monophosphate and methyl xanthines on pancreatic exocrine secretion.

Authors:  R M Case; T Scratcherd
Journal:  J Physiol       Date:  1972-06       Impact factor: 5.182

View more
  6 in total

1.  Pharmacological and biochemical effects of the cardiotonic agent Org10325 in isolated cardiac and vascular tissue preparations.

Authors:  M Shahid; M G Martorana; J E Cottney; R J Marshall
Journal:  Br J Pharmacol       Date:  1990-08       Impact factor: 8.739

2.  Proceedings of the British Pharmacological Society. Oxford, 9th-11th September 1987. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1987-12       Impact factor: 8.739

3.  The metabolism of cyclic nucleotides in the guinea-pig pancreas. Adenylate cyclase and guanylate cyclase.

Authors:  M Lemon; P Methven; K Bhoola
Journal:  Biochem J       Date:  1980-02-15       Impact factor: 3.857

4.  Cyclic AMP phosphodiesterase activity during differentiation of rabbit erythroid bone marrow cells.

Authors:  M S Setchenska; H R Arnstein; J G Vassileva-Popova
Journal:  Biochem J       Date:  1981-06-15       Impact factor: 3.857

5.  Chronotropic and inotropic actions of amrinone, carbazeran and isobutylmethyl xanthine: role of phosphodiesterase inhibition.

Authors:  M Shahid; I W Rodger
Journal:  Br J Pharmacol       Date:  1989-09       Impact factor: 8.739

6.  Comparison of cyclic nucleotide phosphodiesterase isoenzymes in rat and rabbit ventricular myocardium: positive inotropic and phosphodiesterase inhibitory effects of Org 30029, milrinone and rolipram.

Authors:  M Shahid; C D Nicholson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-12       Impact factor: 3.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.